Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05795439 · ClinicalTrials.gov registry record · NA
The CARING Study: Creating and Restoring Health Through Nutrition Guidance
A NA study of Type 2 Diabetes and Type 2 Diabetes Treated With Insulin, sponsored by Physicians Committee for Responsible Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 1
- Study location
NCT05795439: Recruiting NA study of Type 2 Diabetes and Type 2 Diabetes Treated With Insulin, sponsored by Physicians Committee for Responsible Medicine.
NCT05795439 is a NA study of Type 2 Diabetes and Type 2 Diabetes Treated With Insulin that is actively recruiting participants, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 700 participants, below the 3,922-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05795439, a NA study of Type 2 Diabetes and Type 2 Diabetes Treated With Insulin, is actively recruiting participants, sponsored by Physicians Committee for Responsible Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 1
- Study location
Study Summary
The CARING study assesses the health benefits of nutrition education for Blue Cross Blue Shield subscribers, as well as potential healthcare cost savings to subscribers and the insurance company.
Primary Outcome
This study will assess the effectiveness of a series of plant-based nutrition classes on health changes, measured by combined subscriber and insurance total cost of care (healthcare and health benefits).
Conditions Studied
Interventions
- BEHAVIORAL Low-fat, vegan diet
Study Locations (1)
District of Columbia
- Physicians Committee for Responsible Medicine - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05795439 shows while recruiting
NCT05795439 is an interventional study that assigns participants to a tested intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 3,922-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Low-fat, vegan diet is the first listed.
NCT05795439 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05795439 about?
NCT05795439 is a clinical study titled "The CARING Study: Creating and Restoring Health Through Nutrition Guidance". The CARING study assesses the health benefits of nutrition education for Blue Cross Blue Shield subscribers, as well as potential healthcare cost savings to subscribers and the insurance company.
What is the current status of trial NCT05795439?
This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2023-07-11. Estimated completion is 2026-12.
What conditions does trial NCT05795439 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Type 2 Diabetes Treated With Insulin.
What interventions are being tested in trial NCT05795439?
The interventions under investigation include: Low-fat, vegan diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT05795439?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05795439 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05795439's enrollment target sits among peer trials
700 35th of 327 higher than 293 of 327 other Type 2 Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02129543 · 700 participants
Immune Reconstitution in Stem Cell Transplant Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI